Targeted cancer therapies; FDA approval overview.

被引：0
|
作者：
Cortazar, P. [1 ]
Keegan, P. [1 ]
Justice, R. L. [1 ]
Johnson, J. R. [1 ]
Pazdur, R. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2537
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2537
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant breast cancer: FDA approval overview
    Cortazar, P.
    Johnson, J.
    Justice, R.
    Pazdur, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Overview of targeted therapies for cancer
    Finley, RS
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (24) : S4 - S10
  • [3] Metastatic breast cancer (MBC): FDA approval overview
    Cortazar, P.
    Johnson, J. R.
    Justice, R.
    Pazdur, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] PROGRESS IN TARGETED THERAPIES FOR CANCER: OVERVIEW
    Solomon, Benjamin
    Zalcberg, John
    CANCER FORUM, 2008, 32 (03)
  • [5] Trends in the approval of cancer therapies by the FDA in the twenty-first century
    Emma C. Scott
    Andrea C. Baines
    Yutao Gong
    Rodney Moore
    Gulsum E. Pamuk
    Haleh Saber
    Ashim Subedee
    Matthew D. Thompson
    Wenming Xiao
    Richard Pazdur
    V. Ashutosh Rao
    Julie Schneider
    Julia A. Beaver
    Nature Reviews Drug Discovery, 2023, 22 : 625 - 640
  • [6] Trends in the approval of cancer therapies by the FDA in the twenty-first century
    Scott, Emma C.
    Baines, Andrea C.
    Gong, Yutao
    Moore Jr, Rodney
    Pamuk, Gulsum E.
    Saber, Haleh
    Subedee, Ashim
    Thompson, Matthew D.
    Xiao, Wenming
    Pazdur, Richard
    Rao, V. Ashutosh
    Schneider, Julie
    Beaver, Julia A.
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 625 - 640
  • [7] Overview of FDA Drug Approval and Labeling
    Clarridge, Katherine E.
    Chin, Stacy J.
    Stone, Kelly D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12): : 3051 - 3056
  • [8] Pioneering apoptosis-targeted cancer drug poised for FDA approval
    Asher Mullard
    Nature Reviews Drug Discovery, 2016, 15 : 147 - 149
  • [9] Pioneering apoptosis-targeted cancer drug poised for FDA approval
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (03) : 147 - U83
  • [10] Cardiotoxic safety communications after FDA approval of novel cancer therapies.
    Bonsu, Janice
    Kola-Kehinde, Onaopepo
    Kim, Lisa
    Ruz, Patrick
    Lustberg, Maryam B.
    Brammer, Jonathan Edward
    Addison, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345